0000950170-24-001849.txt : 20240104 0000950170-24-001849.hdr.sgml : 20240104 20240104160745 ACCESSION NUMBER: 0000950170-24-001849 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powl Brian T. CENTRAL INDEX KEY: 0001934232 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37620 FILM NUMBER: 24511876 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kura Oncology, Inc. CENTRAL INDEX KEY: 0001422143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 611547851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP III DATE OF NAME CHANGE: 20071227 4 1 ownership.xml 4 X0508 4 2024-01-02 0001422143 Kura Oncology, Inc. KURA 0001934232 Powl Brian T. C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 false true false false Chief Commercial Officer false Common Stock 2024-01-02 4 A false 15000 0 A 15000 D Option to purchase common stock 15.36 2024-01-02 4 A false 30000 0 A 2034-01-01 Common Stock 30000 30000 D Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28. This option vests in 48 equal monthly installments commencing on the grant date. Teresa Bair, Attorney-in-fact for Brian Powl 2024-01-04